Krka Rosvera (Rosuvastatin)

Rosvera is a prescription medication containing the active ingredient Rosuvastatin, primarily used to treat high cholesterol and prevent cardiovascular diseases. The brand is developed and produced by Krka, a leading generic pharmaceutical company based in Central Europe.

Krka, d. d., Novo mesto, is a Slovenian multinational corporation that manages the entire production cycle from research and development to the final manufacturing of products. Rosvera is manufactured in Krka’s high-tech production facilities located in Slovenia, which adhere to strict European Good Manufacturing Practice (GMP) standards.

The brand remains under the ultimate ownership of Krka, which is a publicly-traded company listed on the Ljubljana and Warsaw stock exchanges. It serves over 70 markets worldwide, with a particularly strong presence in Eastern and South-Eastern Europe, where it provides affordable generic alternatives to name-brand medications.